IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action

10.1007/s00395-021-00893-5

Saved in:

Bibliographic Details
Main Authors:	Lecour, Sandrine, Andreadou, Ioanna, Bøtker, H.E., Davidson, Sean M., Heusch, Gerd, Ruiz-Meana, Marisol, Schulz, Rainer, Zuurbier, Coert J., Ferdinandy, Peter, Hausenloy, Derek J., Adamovski, P., Batirel, S., Barteková, M., Bertrand, L., Beauloye, C., Biedermann, D., Borutaite, V., Chlopicki, S., Dambrova, M., Devaux, Y., Di Lisa, F., Djuric, D., Erlinge, D., Falcao-Pires, I., Galatou, E., Garcia-Sosa, A., Girao, H., Giricz, Z., Gyongyosi, M., Healy, D., Jakovljevic, V., Jovanic, J., Kararigas, G., Kerkal, R., Kolar, F., Kwak, B., Leszek, P., Liepinsh, E., Lonborg, J., Longnus, S., Marinovic, J., Muntean, D.M., Nezic, L., Ovize, M., Pagliaro, P., Da Costa Gomes, C.P., Pernow, J., Persidis, A., Pischke, S.E., Podesser, B., Poto?njak, I., Prunier, F., Ravingerova, T., Serban, A., Slagsvold, K., van Royen, N., Turan, B., Vendelin, M., Walsh, S., Zidar, N., Yellon, D., on behalf ofthe European Union-CARDIOPROTECTION COST ACTION CA16225.
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Review
Published:	Springer Science and Business Media Deutschland GmbH 2022
Subjects:	Cardioprotection Drug development Infarction Ischemia Reperfusion
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/232890
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-232890
record_format	dspace
spelling	sg-nus-scholar.10635-2328902022-10-13T01:17:20Z IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action Lecour, Sandrine Andreadou, Ioanna Bøtker, H.E. Davidson, Sean M. Heusch, Gerd Ruiz-Meana, Marisol Schulz, Rainer Zuurbier, Coert J. Ferdinandy, Peter Hausenloy, Derek J. Adamovski, P. Batirel, S. Barteková, M. Bertrand, L. Beauloye, C. Biedermann, D. Borutaite, V. Chlopicki, S. Dambrova, M. Davidson, Sean M. Devaux, Y. Di Lisa, F. Djuric, D. Erlinge, D. Falcao-Pires, I. Galatou, E. Garcia-Sosa, A. Girao, H. Giricz, Z. Gyongyosi, M. Hausenloy, Derek J. Healy, D. Jakovljevic, V. Jovanic, J. Kararigas, G. Kerkal, R. Kolar, F. Kwak, B. Leszek, P. Liepinsh, E. Lonborg, J. Longnus, S. Marinovic, J. Muntean, D.M. Nezic, L. Ovize, M. Pagliaro, P. Da Costa Gomes, C.P. Pernow, J. Persidis, A. Pischke, S.E. Podesser, B. Poto?njak, I. Prunier, F. Ravingerova, T. Serban, A. Slagsvold, K. van Royen, N. Turan, B. Vendelin, M. Walsh, S. Zidar, N. Zuurbier, Coert J. Yellon, D. on behalf ofthe European Union-CARDIOPROTECTION COST ACTION CA16225. DUKE-NUS MEDICAL SCHOOL Cardioprotection Drug development Infarction Ischemia Reperfusion 10.1007/s00395-021-00893-5 Basic Research in Cardiology 116 1 52 2022-10-13T01:17:19Z 2022-10-13T01:17:19Z 2021-09-13 Review Lecour, Sandrine, Andreadou, Ioanna, Bøtker, H.E., Davidson, Sean M., Heusch, Gerd, Ruiz-Meana, Marisol, Schulz, Rainer, Zuurbier, Coert J., Ferdinandy, Peter, Hausenloy, Derek J., Adamovski, P., Batirel, S., Barteková, M., Bertrand, L., Beauloye, C., Biedermann, D., Borutaite, V., Chlopicki, S., Dambrova, M., Davidson, Sean M., Devaux, Y., Di Lisa, F., Djuric, D., Erlinge, D., Falcao-Pires, I., Galatou, E., Garcia-Sosa, A., Girao, H., Giricz, Z., Gyongyosi, M., Hausenloy, Derek J., Healy, D., Jakovljevic, V., Jovanic, J., Kararigas, G., Kerkal, R., Kolar, F., Kwak, B., Leszek, P., Liepinsh, E., Lonborg, J., Longnus, S., Marinovic, J., Muntean, D.M., Nezic, L., Ovize, M., Pagliaro, P., Da Costa Gomes, C.P., Pernow, J., Persidis, A., Pischke, S.E., Podesser, B., Poto?njak, I., Prunier, F., Ravingerova, T., Serban, A., Slagsvold, K., van Royen, N., Turan, B., Vendelin, M., Walsh, S., Zidar, N., Zuurbier, Coert J., Yellon, D., on behalf ofthe European Union-CARDIOPROTECTION COST ACTION CA16225. (2021-09-13). IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action. Basic Research in Cardiology 116 (1) : 52. ScholarBank@NUS Repository. https://doi.org/10.1007/s00395-021-00893-5 0300-8428 https://scholarbank.nus.edu.sg/handle/10635/232890 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ Springer Science and Business Media Deutschland GmbH Scopus OA2021
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Cardioprotection Drug development Infarction Ischemia Reperfusion
spellingShingle	Cardioprotection Drug development Infarction Ischemia Reperfusion Lecour, Sandrine Andreadou, Ioanna Bøtker, H.E. Davidson, Sean M. Heusch, Gerd Ruiz-Meana, Marisol Schulz, Rainer Zuurbier, Coert J. Ferdinandy, Peter Hausenloy, Derek J. Adamovski, P. Batirel, S. Barteková, M. Bertrand, L. Beauloye, C. Biedermann, D. Borutaite, V. Chlopicki, S. Dambrova, M. Davidson, Sean M. Devaux, Y. Di Lisa, F. Djuric, D. Erlinge, D. Falcao-Pires, I. Galatou, E. Garcia-Sosa, A. Girao, H. Giricz, Z. Gyongyosi, M. Hausenloy, Derek J. Healy, D. Jakovljevic, V. Jovanic, J. Kararigas, G. Kerkal, R. Kolar, F. Kwak, B. Leszek, P. Liepinsh, E. Lonborg, J. Longnus, S. Marinovic, J. Muntean, D.M. Nezic, L. Ovize, M. Pagliaro, P. Da Costa Gomes, C.P. Pernow, J. Persidis, A. Pischke, S.E. Podesser, B. Poto?njak, I. Prunier, F. Ravingerova, T. Serban, A. Slagsvold, K. van Royen, N. Turan, B. Vendelin, M. Walsh, S. Zidar, N. Zuurbier, Coert J. Yellon, D. on behalf ofthe European Union-CARDIOPROTECTION COST ACTION CA16225. IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
description	10.1007/s00395-021-00893-5
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Lecour, Sandrine Andreadou, Ioanna Bøtker, H.E. Davidson, Sean M. Heusch, Gerd Ruiz-Meana, Marisol Schulz, Rainer Zuurbier, Coert J. Ferdinandy, Peter Hausenloy, Derek J. Adamovski, P. Batirel, S. Barteková, M. Bertrand, L. Beauloye, C. Biedermann, D. Borutaite, V. Chlopicki, S. Dambrova, M. Davidson, Sean M. Devaux, Y. Di Lisa, F. Djuric, D. Erlinge, D. Falcao-Pires, I. Galatou, E. Garcia-Sosa, A. Girao, H. Giricz, Z. Gyongyosi, M. Hausenloy, Derek J. Healy, D. Jakovljevic, V. Jovanic, J. Kararigas, G. Kerkal, R. Kolar, F. Kwak, B. Leszek, P. Liepinsh, E. Lonborg, J. Longnus, S. Marinovic, J. Muntean, D.M. Nezic, L. Ovize, M. Pagliaro, P. Da Costa Gomes, C.P. Pernow, J. Persidis, A. Pischke, S.E. Podesser, B. Poto?njak, I. Prunier, F. Ravingerova, T. Serban, A. Slagsvold, K. van Royen, N. Turan, B. Vendelin, M. Walsh, S. Zidar, N. Zuurbier, Coert J. Yellon, D. on behalf ofthe European Union-CARDIOPROTECTION COST ACTION CA16225.
format	Review
author	Lecour, Sandrine Andreadou, Ioanna Bøtker, H.E. Davidson, Sean M. Heusch, Gerd Ruiz-Meana, Marisol Schulz, Rainer Zuurbier, Coert J. Ferdinandy, Peter Hausenloy, Derek J. Adamovski, P. Batirel, S. Barteková, M. Bertrand, L. Beauloye, C. Biedermann, D. Borutaite, V. Chlopicki, S. Dambrova, M. Davidson, Sean M. Devaux, Y. Di Lisa, F. Djuric, D. Erlinge, D. Falcao-Pires, I. Galatou, E. Garcia-Sosa, A. Girao, H. Giricz, Z. Gyongyosi, M. Hausenloy, Derek J. Healy, D. Jakovljevic, V. Jovanic, J. Kararigas, G. Kerkal, R. Kolar, F. Kwak, B. Leszek, P. Liepinsh, E. Lonborg, J. Longnus, S. Marinovic, J. Muntean, D.M. Nezic, L. Ovize, M. Pagliaro, P. Da Costa Gomes, C.P. Pernow, J. Persidis, A. Pischke, S.E. Podesser, B. Poto?njak, I. Prunier, F. Ravingerova, T. Serban, A. Slagsvold, K. van Royen, N. Turan, B. Vendelin, M. Walsh, S. Zidar, N. Zuurbier, Coert J. Yellon, D. on behalf ofthe European Union-CARDIOPROTECTION COST ACTION CA16225.
author_sort	Lecour, Sandrine
title	IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
title_short	IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
title_full	IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
title_fullStr	IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
title_full_unstemmed	IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
title_sort	improving preclinical assessment of cardioprotective therapies (impact) criteria: guidelines of the eu-cardioprotection cost action
publisher	Springer Science and Business Media Deutschland GmbH
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/232890
_version_	1749178945901690880

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action

Similar Items